Related Experiment Videos
Pancreatic resection: effects on glucose metabolism
1Department of Surgery, Yale University School of Medicine, Section of Surgical Gastroenterology, 333 Cedar Street, New Haven, Connecticut 06520-8062, USA.
World Journal of Surgery
|May 10, 2001
Summary
Pancreatic resection can cause pancreatogenic diabetes, a unique form of glucose intolerance. Surgical techniques sparing the duodenum may reduce the incidence of this condition.
Area of Science:
- Endocrinology
- Gastroenterology
- Surgical Oncology
Background:
- Pancreatic resection leads to hormonal imbalances affecting glucose metabolism.
- The resulting glucose intolerance, termed pancreatogenic diabetes, differs from Type I and Type II diabetes.
- Hormonal deficits like insulin, glucagon, or pancreatic polypeptide (PP) deficiency can occur depending on resection extent and location.
Purpose of the Study:
- To analyze the hormonal consequences of pancreatic resection.
- To differentiate pancreatogenic diabetes from other diabetic forms.
- To evaluate how surgical approaches impact the incidence of diabetes post-pancreatectomy.
Main Methods:
- Review of endocrine abnormalities following pancreatic resections.
- Comparison of distinct features of pancreatogenic diabetes.
- Analysis of diabetes incidence based on surgical techniques (e.g., Whipple, Beger, Frey procedures).
Main Results:
- Pancreatogenic diabetes presents with hepatic insulin resistance and altered peripheral insulin sensitivity, leading to brittle diabetes.
- Distal resections may cause glucagon deficiency (hypoglycemia risk), while proximal resections can lead to PP deficiency (hyperglycemia).
- Duodenum-sparing procedures (Beger, Frey) show a lower incidence of new or worsened diabetes compared to Whipple or total pancreatectomy.
Conclusions:
- Surgical strategies for pancreatic disease should aim to minimize hormonal deficits.
- Duodenum-preserving pancreatic resections may offer better metabolic outcomes.
- Understanding these hormonal and metabolic changes is crucial for managing patients post-pancreatic surgery.